Zheng Fu Selected Research

Radiation Pneumonitis

11/2015	18FDG PET-CT standardized uptake value for the prediction of radiation pneumonitis in patients with lung cancer receiving radiotherapy.
12/2012	Functional and biologic metrics for predicting radiation pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy.
8/2009	[Application of standardized uptake value for FDG PET-CT in predicting radiation pneumonitis].
6/2009	[18F]2-fluoro-2-deoxyglucose positron emission tomography/computed tomography in predicting radiation pneumonitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zheng Fu Research Topics

Disease

77	Neoplasms (Cancer) 01/2024 - 04/2004
22	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2006
17	Neoplasm Metastasis (Metastasis) 01/2023 - 06/2003
15	Lung Neoplasms (Lung Cancer) 01/2023 - 04/2007
8	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 02/2008
7	Breast Neoplasms (Breast Cancer) 01/2024 - 11/2004
6	Prostatic Neoplasms (Prostate Cancer) 05/2022 - 06/2003
5	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 06/2014
5	Carcinoma (Carcinomatosis) 02/2018 - 03/2007
4	Adenocarcinoma 01/2023 - 11/2004
4	Infections 01/2023 - 01/2016
4	Stomach Neoplasms (Stomach Cancer) 12/2017 - 04/2007
4	Radiation Pneumonitis 11/2015 - 06/2009
3	Ovarian Neoplasms (Ovarian Cancer) 12/2023 - 06/2017
3	COVID-19 12/2023 - 07/2021
3	Drug-Related Side Effects and Adverse Reactions 11/2023 - 03/2008
3	Inflammation (Inflammations) 10/2023 - 12/2017
3	Spinal Cord Injuries (Spinal Cord Injury) 01/2023 - 05/2015
3	Glioma (Gliomas) 12/2017 - 05/2008
3	Leukemia 06/2017 - 04/2007
3	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2012 - 07/2012
2	Osteosarcoma (Osteogenic Sarcoma) 08/2023 - 12/2017
2	Ganglioneuroblastoma 01/2023 - 01/2022
2	Carcinogenesis 01/2023 - 01/2017
2	Neuroblastoma 01/2023 - 01/2022
2	Wounds and Injuries (Trauma) 08/2021 - 04/2017
2	Fibrosis (Cirrhosis) 06/2021 - 10/2008
2	Hypoxia (Hypoxemia) 10/2019 - 06/2010
2	Squamous Cell Carcinoma of Head and Neck 10/2019 - 12/2002
2	Head and Neck Neoplasms (Head and Neck Cancer) 10/2019 - 07/2011
2	Esophageal Squamous Cell Carcinoma 01/2019 - 02/2018
2	Melanoma (Melanoma, Malignant) 07/2018 - 04/2007
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 10/2014
2	Liver Neoplasms (Liver Cancer) 03/2017 - 06/2015
2	Colonic Neoplasms (Colon Cancer) 03/2016 - 01/2013
2	Alzheimer Disease (Alzheimer's Disease) 02/2016 - 12/2013
2	Lewis Lung Carcinoma 01/2015 - 04/2007
2	Starvation 01/2014 - 04/2012
2	Allergic Rhinitis 04/2013 - 01/2011
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 05/2009 - 08/2006

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2003
22	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023 - 08/2006
11	Messenger RNA (mRNA)IBA 01/2020 - 12/2002
9	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2016
7	RNA (Ribonucleic Acid)IBA 08/2023 - 02/2016
6	H-Tyr-Ser-Leu-OHIBA 01/2018 - 10/2005
6	tripeptide tyroservatideIBA 01/2016 - 03/2006
5	Phosphotransferases (Kinase)IBA 01/2023 - 01/2014
4	Long Noncoding RNAIBA 01/2023 - 12/2017
4	Small Interfering RNA (siRNA)IBA 01/2022 - 04/2004
4	Therapeutic UsesIBA 01/2022 - 01/2016
4	Glucose (Dextrose)FDA LinkGeneric 06/2017 - 01/2007
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2017 - 06/2008
4	Phosphatidylethanolamine Binding ProteinIBA 02/2006 - 06/2003
3	Indicators and Reagents (Reagents)IBA 06/2023 - 03/2009
3	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 06/2008
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2016
3	Peptides (Polypeptides)IBA 01/2022 - 02/2014
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 03/2016
3	Polo-Like Kinase 1IBA 01/2021 - 03/2016
3	LigandsIBA 01/2020 - 02/2009
3	Cyclin D1IBA 11/2019 - 07/2010
3	PlatinumIBA 06/2017 - 10/2014
3	ErbB Receptors (EGF Receptor)IBA 01/2015 - 12/2002
3	alovudineIBA 01/2015 - 07/2010
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2009 - 01/2006
2	palbociclibIBA 01/2024 - 11/2019
2	CytokinesIBA 10/2023 - 02/2018
2	Histone Deacetylase InhibitorsIBA 08/2023 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2022
2	FluorineIBA 01/2023 - 06/2017
2	VimentinIBA 01/2023 - 01/2017
2	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 10/2022 - 01/2022
2	AntibodiesIBA 01/2022 - 06/2017
2	IntegrinsIBA 01/2022 - 01/2016
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2022 - 01/2015
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 01/2012
2	alfatide IIIBA 01/2022 - 01/2015
2	Monoclonal AntibodiesIBA 01/2022 - 06/2021
2	CalciumIBA 01/2021 - 10/2005
2	CyclinsIBA 11/2019 - 08/2009
2	fluoroerythronitroimidazoleIBA 10/2019 - 06/2010
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019 - 01/2014
2	Protein Kinases (Protein Kinase)IBA 01/2019 - 01/2013
2	Polysaccharides (Glycans)IBA 07/2018 - 04/2017
2	Fluorine-18IBA 01/2018 - 11/2015
2	Galactose (Galactopyranose)FDA LinkGeneric 06/2017 - 03/2016
2	GTP-Binding Proteins (G-Protein)IBA 03/2017 - 04/2012
2	Leucovorin (Folinic Acid)FDA Link 08/2015 - 06/2008
2	DNA (Deoxyribonucleic Acid)IBA 05/2015 - 04/2004
2	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 01/2015 - 01/2015
2	Transforming Growth Factor-beta Type II ReceptorIBA 01/2015 - 01/2015
2	AntigensIBA 09/2014 - 10/2008
2	Exenatide (Byetta)FDA Link 09/2012 - 07/2012

Therapy/Procedure

15	Therapeutics 08/2023 - 05/2008
15	Radiotherapy 01/2022 - 01/2006
8	Chemoradiotherapy 01/2022 - 10/2008
6	Drug Therapy (Chemotherapy) 01/2023 - 07/2007
3	Aftercare (After-Treatment) 07/2011 - 04/2004
2	Subcutaneous Injections 03/2017 - 05/2008